Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 1880.1× sales vs its 30.0× historical median P/S.
Fair value ≈ $0.00 · price $0.08 today
Overvalued · 6172% above
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$NDATF $NDAT Very informative article by Digital Health Buzz on Substack released Dec 18, 2024 https://www.digitalhealthbuzz.news/p/revolutionizing-mental-health-diagnosis?r=3n87gh&utm_campaign=post&utm_medium=web&showWelcomeOnShare=false
$NDATF News release Dec12, 2024
nDatalyze Corp. Announces its AI-based Depression Assessment Availability Through the Largest Canadian Electronic Medical Record ("EMR ") Platforms.
https://research.quotemedia.com/home/news?symbol=NDAT:CNX&qmodStoryID=7866043423590298
$NDATF nDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTCQB:NDATF) Completes Reversal of the Mindbalanced Acquisition https://research.quotemedia.com/home/news?symbol=NDAT:CNX&qmodStoryID=8165304797463890
$NDATF News Release October 8, 2024
nDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTCQB:NDATF) announces positive Clinical Study results, and Mindbalanced update. https://research.quotemedia.com/home/overview?symbol=NDATF&qmodStoryID=7724987049790165
